Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Identifying individuals at risk of Alzheimer's disease (AD), particularly in the preclinical and ear...
Addressing the computational efficiency and cross-device generalization challenges faced by acoustic...
Explainable Artificial Intelligence (XAI) is gaining popularity in early diagnosis and monitoring of...
Verbal fluency tasks are ubiquitous in mild cognitive impairment (MCI) screenings. Yet, their assess...
We introduce a quantitative pipeline for region-level explanations of an Alzheimer's prediction mode...
OBJECTIVE: Reliable assessment of cerebral amyloid-β (Aβ) deposition is essential for the diagnosis ...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive impa...
INTRODUCTION: Seizure control is the primary therapeutic goal in pediatric epilepsy, yet its multidi...
BACKGROUND: Although large language models (LLMs) show potential for patient education, their accura...
BACKGROUND: Family caregivers experience conflicts in caring for people with Alzheimer's dementia (P...
Heparan sulfate (HS) proteoglycans are abundant, sulfation-patterned glycosaminoglycans on brain cel...
BackgroundThe systemic, metabolic, lifestyle factors have established associations with Alzheimer's ...
BACKGROUND: Everyday listening ability is essential for individual health and well-being. Age-relate...
The quick and accurate diagnosis of Alzheimer's disease (AD) and Frontotemporal Dementia (FTD) is a ...
UNLABELLED: Mild cognitive impairment (MCI) is a heterogeneous condition, with up to 40% of patients...
PURPOSE: Amyloid (A) deposition represents a specific pathological hallmark of Alzheimer's disease (...
With the rapid development of artificial intelligence and medical image analysis, MRI-based automate...
IMPORTANCE: Cognitive impairment (CI) is often underdetected in primary care due to time and resourc...
BACKGROUND AND OBJECTIVES: Population aging and the rising prevalence of Alzheimer's Disease and Rel...
Alzheimer's disease (AD) plasma and cerebrospinal fluid (CSF) proteomics can distinguish AD from cog...
Aging is asynchronous across cells and organs. Here we tested whether plasma proteomics can be used ...